Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04669457 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pediatric Delirium

StatusEnrolling by Invitation
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Re-verified, no change to tracked fieldsv11
  2. Notable Primary and study completion dates: Apr 5, 2026 to Apr 5, 2027v10
  3. Notable Trial status: Suspended to Enrolling by Invitation
    • Primary and study completion dates: May 13, 2025 to Apr 5, 2026
    v9
  4. Stopped Trial status: Recruiting to Suspended Sponsor's reason: Expiration of IRB Approval
    • Primary and study completion dates: Dec 31, 2024 to May 13, 2025
    • Site details revised
    v8
  5. Notable Primary and study completion dates: Dec 31, 2023 to Dec 31, 2024v7
Show 5 earlier versionsHide 5 earlier versions
  1. Notable Primary completion date: Dec 31, 2022 to Dec 31, 2023
    • Study completion date: Aug 30, 2023 to Dec 31, 2023
    v6
  2. Minor Re-verified, no change to tracked fieldsv5
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Apr 1, 2021 to Apr 27, 2021
    v4
  4. Notable Start date: Jan 1, 2021 to Apr 1, 2021v3
  5. Minor Re-verified, no change to tracked fieldsv2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Preventing emergent delirium in pediatric ambulatory surgery through preoperative use of intra-nasal Dexmedetomidine and oral Midazolam.
Trial Details
NCT Number NCT04669457
Lead Sponsor University of Massachusetts, Worcester
Conditions
(from sponsor)
Pediatric Delirium
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov